Feature | December 23, 2013

WHO Study: Atrial Fibrillation is a Growing Global Health Concern

December 23, 2013 — Atrial fibrillation (AF), long considered the most common condition leading to an irregular heartbeat, is a growing and serious global health problem, according to the first study ever to estimate the condition’s worldwide prevalence, death rates and societal costs.
 
The World Health Organization (WHO) data analysis, led by Sumeet Chugh, M.D., associate director, Cedars-Sinai Heart Institute, shows 33.5 million people worldwide — or 0.5 percent of the world’s population — have the condition. Funded partly by the Bill & Melinda Gates Foundation and the Cedars-Sinai Heart Institute, the analysis was conducted with the assistance of the University of Washington University’s Institute for Health Metrics and Evaluation.
 
The study, believed to be the first to determine the number of people globally with AF, is published online in the peer reviewed medical journal Circulation and is scheduled to be published in the Feb. 25 print edition of the journal.
 
“Atrial fibrillation has a huge cost in every sense of the word,” said Chugh. “It can lead to stroke, hospitalization, as well as lost productivity. Our findings indicate that atrial fibrillation is on the rise around the world and it’s a huge public health burden.”
 
During the analysis, Chugh and a team of researchers systematically analyzed data from selected population-based research studies — from among 1,784 published medical research studies on AF — to estimate global and regional prevalence, incidence and mortality related to this condition.
 
“Finding out the scope of the problem is step No. 1,” said Chugh. “Our hope is that we can develop a sustainable global plan to manage atrial fibrillation and find new and effective ways of preventing this condition.”
 
Among the study’s findings:
  • In 1990, an estimated 570 of 100,000 men had AF. In 2010, the prevalence rate for men was 596 of 100,000.
  • For females, an estimated 360 of 100,000 women had AF in 1990. In 2010, that rose to 373 of 100,000.
  • In 1990, the number of new cases of AF in men was estimated at 61 per 100,000. In 2010, the number of men with new cases of AF rose to 78 per 100,000.
  • The number of new cases of AF in women was 43 per 100,000 in 1990. In 2010, the number of new cases in women was 60 per 100,000.
  • Although deaths linked to AF are rising around the world, more women with AF are dying in developing countries. In the United States, deaths linked to AF now are comparable between the sexes.
 
“A lot more research is needed to fully understand this continuing worldwide increase,” said Chugh. “Although the chance of developing atrial fibrillation does increase with age, these findings are not entirely explained by the aging world population. Several other factors have been suggested and need to be better evaluated, from obesity and hypertension to air pollution.”
 
For more information: cedars-sinai.edu, circ.ahajournals.org

Related Content

HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA)| May 23, 2016
First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict...
Boston Scientific, FDA, IntelliNav XP ablation catheters, Rhythmia Mapping System

Rhythmia Mapping System image courtesy of Boston Scientific

Technology | Ablation Systems| May 23, 2016
Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with...
TAVR outcomes, aortic valve gradient, JACC study
News | Heart Valve Technology| May 23, 2016
Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher mortality rates...
Direct Flow Medical, TAVR device, DISCOVER trial, three-year results, EuroPCR 2016
News | Heart Valve Technology| May 20, 2016
Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR...
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders| May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk
News | Atrial Fibrillation| May 19, 2016
Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision...
Bioventrix, Revivent-TC System, heart failure, first-in-man procedure
News | Heart Failure| May 19, 2016
BioVentrix announced the first-in-man use of its next-generation Revivent-TC System with an endovascular catheter-based...
St. Jude Medical, EuroPCR 2016 studies, FFR, LAAO, left atrial appendage occlusion, fractional flow reserve, Amplatzer
News | Cath Lab| May 19, 2016
St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR 2016.
bioabsorbable vascular graft, children, feasibility study, Bakoulev Center Moscow, AATS 2016 meeting

Image courtesy of Bakoulev Scientific Center for Cardiovascular Surgery

News | Stent Grafts| May 18, 2016
Bioabsorbable heart valves or blood vessels are designed to harness the body’s innate healing process, enabling the...
RDAVR, aortic valve replacement, Edwards Intuity, TRANSFORM Trial, AATS meeting
News | Heart Valve Technology| May 18, 2016
The TRANSFORM trial was designed to evaluate the safety and performance of an investigational rapid deployment aortic...
Overlay Init